| Literature DB >> 35990249 |
Jianguo Zhou1, Dayong Fu1, Yun Meng1, Mingcong Lu1, Fangyun Hu1, Hongke Cheng2.
Abstract
Objective: To explore the value of three-dimensional- (3D-) arterial spin labeling (ASL) technique in evaluating cerebral perfusion in patients with unilateral middle cerebral artery occlusion (MCAO) and to observe the influencing factors of poor prognosis via long-term follow-up of patients who survived the disease.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35990249 PMCID: PMC9385308 DOI: 10.1155/2022/6990590
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.464
Comparison of CBF between the affected side and the contralateral side in patients with unilateral MCAO.
| Postlabeling delay | CBF of the affected side (mL/(100 g·min)) | CBF of the mirror side (mL/(100 g·min)) |
|
| |
|---|---|---|---|---|---|
| Left MCAO ( | 1525 ms | 22.95 ± 9.69 | 44.39 ± 10.21 | 2.7089 | <0.0001 |
| 2525 ms | 41.96 ± 10.17∗ | 47.46 ± 9.68 | 2.7021 | 0.0469 | |
|
| |||||
| Right MCAO ( | 1525 ms | 30.17 ± 11.38 | 48.08 ± 10.08 | 2.6464 | <0.0001 |
| 2525 ms | 44.13 ± 10.52∗ | 50.24 ± 9.57 | 2.4757 | 0.0163 | |
|
| |||||
| Unilateral MCAO ( | 1525 ms | 27.00 ± 11.36 | 46.50 ± 10.11 | 9.9325 | <0.0001 |
| 2525 ms | 43.15 ± 9.78∗ | 49.28 ± 9.87 | 3.4173 | 0.0008 | |
Note: ∗P < 0.05 vs. ipsilateral 1525 ms group; CBF: cerebral blood flow; MCAO: middle cerebral artery occlusion.
Figure 1Regions of interest in the blood supply region of two patients' brains. (a) MRA indicated occlusion of M1 segment of the right MCA; (b) DWI showed negative; (c) ASL suggested that the CC was well established (PLD 2525 ms); (d) MRA showed that the M1 segment of the right MCA was occluded; (e) DWI showed negative; (f) ASL indicated insufficient collateral circulation (PLD 2525 ms).
Comparison of perfusion status between the affected side and mirror side of patients with unilateral MCAO.
| rCBF | 1525 ms | 2525 ms |
|
|
|---|---|---|---|---|
| <0.9 ( | 25.30 ± 4.88 | 33.96 ± 5.92 | 7.4018 | <0.0001 |
| 0.9-1.1 ( | 36.62 ± 2.64 | 43.71 ± 4.21 | 4.2803 | 0.0005 |
| >1.1 ( | 50.36 ± 2.96 | 52.13 ± 1.93 | 1.4168 | 0.1784 |
Note: MCAO: middle cerebral artery occlusion; rCBF: relative cerebral blood flow.
Comparison of baseline data between the two groups.
| Factors | Good prognosis group ( | Poor prognosis group ( |
|
|
|---|---|---|---|---|
| Sex (male/female) | 19/15 | 15/11 | 0.0197 | 0.8885 |
| Age (years old) | 54.00 ± 6.88 | 57.69 ± 6.55 | 2.7479 | 0.0080 |
| Location of vascular occlusion | 0.0247 | 0.8752 | ||
| Left middle cerebral artery | 15 (44.12) | 12 (46.15) | ||
| Right middle cerebral artery | 19 (55.88) | 14 (53.85) | ||
| Collateral circulation | 5.6681 | 0.0173 | ||
| Good | 21 (61.76) | 8 (30.77) | ||
| Poor | 13 (38.24) | 18 (69.23) | ||
| Smoking history | 14 (41.18) | 10 (38.46) | 0.0453 | 0.8315 |
| Drinking history | 19 (55.88) | 16 (61.54) | 0.1939 | 0.6597 |
| History of hypertension | 13 (38.24) | 11 (42.31) | 0.1018 | 0.7497 |
| History of diabetes | 14 (41.18) | 9 (34.62) | 0.2683 | 0.6045 |
| History of coronary heart disease | 16 (47.06) | 12 (46.15) | 0.0048 | 0.9445 |
| NIHSS score (median (lower quartile, upper quartile)) | 3 (1.11) | 8 (4.13) | 3.0140 | 0.0038 |
| Laboratory inspection index | ||||
| Total cholesterol (mmol/L) | 4.63 ± 1.31 | 4.54 ± 0.78 | 0.3104 | 0.7574 |
| Triglyceride (mmol/L) | 2.12 ± 0.94 | 1.32 ± 0.56 | 3.8447 | 0.0003 |
| High-density lipoprotein (mmol/L) | 1.09 ± 0.27 | 1.02 ± 0.20 | 1.1088 | 0.2721 |
| Low-density lipoprotein (mmol/L) | 2.80 ± 0.59 | 2.63 ± 0.69 | 1.0275 | 0.3084 |
| Platelet count (×109/L) | 224.99 ± 30.50 | 228.68 ± 51.97 | 0.3442 | 0.7319 |
| White blood cell count (×109/L) | 7.53 ± 1.49 | 7.37 ± 1.95 | 0.3605 | 0.7198 |
| Albumin (g/L) | 39.84 ± 5.02 | 40.35 ± 6.61 | 0.3399 | 0.7352 |
| Hemoglobin (g/L) | 139.13 ± 14.32 | 132.51 ± 14.87 | 1.7453 | 0.0862 |
| Serum creatinine (mmol/L) | 57.75 ± 6.41 | 58.92 ± 6.85 | 0.6801 | 0.4991 |
| Uric acid ( | 279.18 ± 87.93 | 251.76 ± 98.48 | 1.1363 | 0.2605 |
| Urea (mmol/L) | 4.93 ± 1.04 | 5.22 ± 1.05 | 1.0659 | 0.2909 |
| Homocysteine (mmol/L) | 17.71 ± 4.06 | 26.57 ± 9.86 | 4.7489 | <0.0001 |
| Glutamic-pyruvic transaminase | 19.81 ± 3.81 | 20.16 ± 4.77 | 0.3161 | 0.7531 |
Multivariate Logistic regression analysis of prognosis.
| Indicators |
| SE | Wald |
| Exp( | 95% CI |
|---|---|---|---|---|---|---|
| Age (continuous variable) | 0.197 | 0.078 | 6.404 | 0.011 | 1.217 | 1.045-1.418 |
| Collateral circulation (0 = good; 1 = poor) | 2.977 | 1.094 | 7.401 | 0.007 | 19.630 | 2.299-167.640 |
| NIHSS score (continuous variable) | 0.218 | 0.098 | 4.942 | 0.026 | 1.244 | 1.026-1.508 |
| Triglyceride (continuous variable) | -1.089 | 0.629 | 2.991 | 0.084 | 0.337 | 0.098-1.156 |
| Homocysteine (continuous variable) | 0.135 | 0.059 | 5.219 | 0.022 | 1.144 | 1.019-1.284 |
| Constant | -15.383 | 5.498 | 7.829 | 0.005 | 0.000 | - |